Terns Pharmaceuticals, Inc.

Key metrics

Financial performance

Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.

Key statistics

Latest filings

Browse the full filing history (430 filings)

Recent press releases

• Terns Pharmaceuticals Announces FDA Breakthrough Therapy Designation Granted to TERN-701 for Certain Patients with Chronic Myeloid Leukemia2026-04-27

  Terns Pharmaceuticals Announces FDA Breakthrough Therapy Designation Granted to TERN-701 for Certain Patients with Chronic Myeloid Leukemia — Terns Pharmaceuticals, Inc.

• Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)2026-04-02

  Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) — Terns Pharmaceuticals, Inc.

• Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML)2026-03-25

  Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML) — Terns Pharmaceuticals, Inc.

• Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences2026-02-25

  Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences — Terns Pharmaceuticals, Inc.

• Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)2026-02-02

  Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) — Terns Pharmaceuticals, Inc.

Similar companies

The largest companies sharing Terns Pharmaceuticals, Inc.'s SEC industry classification (pharmaceutical preparations).